Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-04 Sale |
2024-03-06 4:46 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
17,411 | $4.2145 | $73,379 | 313,569 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:24 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
16,777 | $6.2338 | $104,584 | 205,980 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:26 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
15,601 | $11.25 | $175,492 | 266,307 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 6:39 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
20,465 | $18.28 | $374,017 | 171,708 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Tax Withholding |
2025-03-04 4:46 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
26,941 | $4.76 | 411,628 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 7:44 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
125,000 | $0 | 438,569 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:50 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
125,000 | $0 | 330,980 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:08 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 300,257 (Direct) |
View |
| 2022-08-26 Exercise |
2022-08-29 5:02 pm |
N/A 2022-12-06 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
1,250 | $0 | 190,057 (Direct) |
View |
| 2022-08-26 Exercise |
2022-08-29 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
1,250 | $3.12 | 190,057 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:26 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 266,307 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 5:15 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 269,673 (Direct) |
View |